Evidence map›Paper›PMID 42649999›Full record

ReviewCancers2026

A Pathway to Chordoma Treatment: A Review on CDKN2A and Therapeutic Targeting.

Muneeb Mohiuddin, Benjamin Vaca, Elijah Haynal, Othman Bin-Alamer, Peter Zaki, Hussam Abou-Al-Shaar, Georgios A Zenonos, Hector A Perez, Miguel Lopez-Gonzalez, Zachary C Gersey

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muneeb MohiuddinDepartment of Neurosurgery, University of Miami, Miami, FL 33136, USA.
Benjamin VacaDepartment of Neurosurgery, University of Miami, Miami, FL 33136, USA.
Elijah HaynalDepartment of Neurosurgery, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0009-0001-5999-2329
Othman Bin-AlamerDepartment of Neurosurgery, University of Utah, Salt Lake City, UT 84132, USA.
Peter ZakiDepartment of Neurosurgery, Loma Linda University, Loma Linda, CA 92354, USA.
Hussam Abou-Al-ShaarDepartment of Neurosurgery, McGovern Medical School, Houston, TX 77030, USA.
Georgios A ZenonosDepartment of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Hector A PerezDepartment of Otolaryngology-Head and Neck Surgery, Loma Linda University, Loma Linda, CA 92350, USA.
Miguel Lopez-GonzalezDepartment of Neurosurgery, Loma Linda University, Loma Linda, CA 92354, USA.ORCID 0000-0002-7172-6963
Zachary C GerseyDepartment of Neurosurgery, Loma Linda University, Loma Linda, CA 92354, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer geneticsCDK inhibitorsCDKN2Achordomaskull base

Identifiers

PMID42649999
PMCPMC13510555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.